Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-150.8%Return on Invested Capital
VS
Market
Sector
Industry
History
$ 0.79Close
$ 0.58 - $ 1.87 52-Week Range
Ticker Information
Ticker
CUECompany Name
CUE BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCUE BIOPHARMA INC - Return on Invested Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CUE - ROIC Historical data
| Date | Invested Capital | Net Income Common Stock | Return on Invested Capital |
|---|---|---|---|
| 6/30/2025 | $ 25.79M | $ -38.9M | -150.8% |
| 3/31/2025 | $ 13.71M | $ -40.58M | -296.13% |
| 12/31/2024 | $ 26.38M | $ -40.67M | -154.21% |
| 9/30/2024 | $ 34.88M | $ -44.61M | -127.91% |
| 6/30/2024 | $ 32.88M | $ -46.96M | -142.79% |
| 3/31/2024 | $ 43.03M | $ -49.97M | -116.12% |
| 12/31/2023 | $ 51.78M | $ -50.73M | -97.98% |
| 9/30/2023 | $ 59.04M | $ -51.89M | -87.89% |
| 6/30/2023 | $ 64.05M | $ -51.84M | -80.94% |
| 3/31/2023 | $ 73.72M | $ -51.86M | -70.35% |
Key Performance Insights, Last 5 Years
- CUE BIOPHARMA INC's latest trailing twelve months (TTM) ROIC stands at -44.49%.
- Over the past 5 years, CUE BIOPHARMA INC's average ROIC has been -95.48%.
- The median ROIC for CUE BIOPHARMA INC during this period was -70.08%
- CUE BIOPHARMA INC reached its highest ROIC over the past 5 years at -44.49%.
- The lowest ROIC recorded by CUE BIOPHARMA INC in the same timeframe -296.13%
CUE BIOPHARMA INC's ROIC vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROIC Benchmarks
Similar metrics to ROIC:
- Cash Return on Invested Capital - [Calculation] Cash Return on Invested Capital (CROIC) measures how well a company uses its invested capital to produce cash. It is calculated as Free Cash Flow [FCF] divided by invested capital [InvCapital].
- Invested Capital - [Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
Definition of Return on Invested Capital
[Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].Net Inc. Cmn. / Inv. Capital
(=) ROIC ROIC for CUE BIOPHARMA INC is calculated as follows: Net Inc. Cmn. [ $ -42.6M ] / Inv. Capital [ $ 95.75M ]
(=) ROIC [ -44.49% ] CUE - Return on Invested Capital, Last 5 years
-296.13%
Minimum
Mar 31, 2025
-44.49%
Maximum
Sep 30, 2020
-95.48%
Average
-70.08%
Median
ROIC Benchmark AnalysisMarket
The chart above depicts the distribution of ROIC for companies in the Total Stock Market. The average ROIC of the companies is 0.68% with a standard deviation of 15.16%.
The following table provides additional summary stats:
ROIC in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | -46.36% |
| max | 48.66% |
| average | 0.68% |
| median | 3.38% |
| std | 15.16% |